PROGRESSING CHRONIC KIDNEY DISEASE AND THE 12-MONTH DYNAMICS OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
https://doi.org/10.15829/1728-8800-2013-5-16-21
Abstract
Aim. To assess the association between the 12-month dynamics of cardiovascular risk factors (CVD RFs), progressing chronic kidney disease (CKD), and individual baseline clinical and laboratory parameters in patients with arterial hypertension (AH) and Type 2 diabetes mellitus (DM-2) who received active antidiabetic treatment.
Material and methods. In total, 122 patients with AH and DM-2 underwent the laboratory assessment of blood and urine samples at baseline and 12 months later, in order to evaluate the levels and dynamics of CVD RFs and CKD severity.
Results. After 12 months of continuous therapy with antihypertensive and oral antidiabetic medications and statins, the carbohydrate metabolism parameters significantly improved. However, creatinine clearance decreased significantly (by 7,52%). The direction of renal function parameter changes was determined by the baseline CKD stage. Progressing CKD was also associated with obesity (O), atrial fibrillation (AF), and myocardial infarction (MI) in medical history. In patients with or without O, the albumin-creatinine ratio decreased by 59,8% and 34%, respectively. In participants with or without AF, microalbuminuria increased by 321% and decreased by 53,5%, respectively. In patients with MI in medical history, urine levels of creatinine decreased by 33,6%, while in the other patients, they increased by 5,4%. O was associated with a reduction in total cholesterol (TCH) by 5,5%, while in non-obese patients, TCH levels did not change substantially.
Conclusion. In most patients with AH and DM-2, adequate glycemia control, standard antihypertensive treatment, and statin therapy for 12 months were associated with minimal changes in CVD RFs and with a significant deterioration in renal function. The latter was predicted by the CKD stage at baseline, O, MI in medical history, and AF.
About the Authors
A. V. Markova
V.I. Razumovskyi Saratov State Medical University, Saratov
Russian Federation
Russian Federation
Yu. G. Schwartz
V.I. Razumovskyi Saratov State Medical University, Saratov
Russian Federation
Russian Federation
References
1. Sampanis С, Zamboulis C. Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia 2008; 12 (2).
2. Smirnov AV, Dobronravov AV, Kayukov IG. Kardiorenal continuum: the pathogenetic basis of preventive nephrology. Nephrology 2005;9 (3):7– 15. Russian (Смирнов А.В., Добронравов А.В., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефро- логии. Нефрология 2005; 9 (3):7–15).
3. Recommendations about preventive maintenance, diagnostics and treatment of an arterial hypertension. The Russian recommendations (the second revision). Cardiovascular Therapy and Prevention 2008; 7 (6) (the Appendix 2). Russian (Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Кардиоваскулярная терапия и профилактика 2008; 7 (6) (Приложение 2)).
4. Diagnostics and correction of lipid disorders with the purpose of prophylaxis and treatment of atherosclerosis. Russian Guidelines. V revision. Russian Journal of Cardiology, 2012;4(96):1-32. Suppl. 1; Russian (Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеро- склероза. Российские рекомендации, V пересмотр. Российский кардиологический журнал 2012;4(96):1-32, Приложение 1).
5. Shilov AM, Avshalumov AS, Markovsky VB, et al. Risk factors of cardiovascular complications at patients with the superfluous weight of a body combined with an arterial hypertension and their correction. RMJ Endokrinologija 2009; 10 (349):2–7. Russian (Шилов А. М., Авшалумов А.Ш., Марковский В.Б. и др. Факторы риска сердечно-сосудистых осложнений у пациентов с избыточной массой тела, сочетающейся с артериальной гипертензией и их коррекция. РМЖ Эндокринология 2009; 10 (349):2–7).
6. Jadzinsky M. Saxagliptin given in combination with metformin as initial therapy improves glycemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes, Obesity and Metabolism 2009;11:611–22.
7. Nedogoda SV, Tsoma VV, Ledjaeva AA. Adherence to therapy statins and possibility of its improvement in the conditions of real clinical practice. RMJ Cardiology 2009; 17 (18):1086–90. Russian (Недогода С.В., Цома В.В., Ледяева А.А. Приверженность к терапии статинами и возможность ее улучшения в условиях реальной клинической практики. РМЖ Кардиология 2009; 17 (18):1086–90).
8. Shoji T, Abe T, Matsuo H, et al. Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis. J Atheroscl Thromb 2012; 19 (4):299–315.
9. Tselujko VI, Lozovaja TA. Feature a profile of cytokine at patients with paroxysms of fibrillation of auricles at an ischemic heart trouble and warm insufficiency “Ukrainsky cardiology magazine” 2007; 4:18–23. Russian (Целуйко В. И., Лозовая Т.А. Особенности цитокинового профиля у больных с пароксизмами фибрилляции предсердий при ишемической болезни сердца и сердечной недостаточности “Український кардіологічний журнал” 2007; 4:18–23).
10. Muhin NA, Fomin VV, Moiseev SV, et al. Microalbuminuria – an integrated marker cardiorenal mutual relations at arterial hypertension. Consilium medicum 2007; 09 (5): 13–9. Russian (Мухин Н.А., Фомин В.В., Моисеев С.В. и др. Микроальбуминурия – интегральный маркер кардиоренальных взаимоотношений при артериальной гипертонии. Consilium medicum 2007; 09 (5):13–9.
11. Chagnac A, Weinstein T, Herman M, et al. The Effects of Weight Loss on Renal Function in Patients with Severe Obesity. J Am Society of Nephrology 2003; 14:1480–6.
12. Kobalava Zh. D. Villevalde S. V., Moiseev V. S. Cardiovascular disease and functional state of the kidneys. Russian journal of cardiology, 2013; 4 (102): 33-37. Russian (Кобалава Ж. Д., Виллевальде С. В., Моисеев В. С. Сердечно-сосудистые заболевания и функциональное состояние почек. Российский кардиологический журнал, 2013; 4 (102): 33-37).
13. Vlasov VV. Epidemiologija: The studies grant for high schools. V. V. Vlasov. – 2 edition corrected. – М: GEOTAR-MEDIA, 2005. 464 p. Russian (Власов В. В. Эпидемиология: учеб. Пособие для вузов/ В. В. Власов. – 2-е изд. испр. – М.: ГЭОТАР-Медиа 2005; 464 с).
Review
For citations:
Markova A.V., Schwartz Yu.G. PROGRESSING CHRONIC KIDNEY DISEASE AND THE 12-MONTH DYNAMICS OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS. Cardiovascular Therapy and Prevention. 2013;12(5):16-21. (In Russ.) https://doi.org/10.15829/1728-8800-2013-5-16-21
Views:
828
Email this article 
